Physician’s Weekly continued its #PWChat series on Thursday, Nov. 16, with Steven P. Levine, MD, on the use of ketamine to treat depression.
The discussion focused on why there is a need for alternatives to antidepressants, like ketamine, for treating depression, how ketamine, a psychedelic club drug, ever became even a possibility for the treatment of depression, what makes ketamine a promising alternative to antidepressants and other standard depression care, and much more.
You can view our upcoming schedule, or read our other #PWChat recaps here.
Below are the highlights from the chat. You can read the full transcript here.
Myocardial infarct size is a key determinant of cardiac mortality to the point that infarct reduction strategies are fundamental to…
Whereas complicated pneumonia is associated with high rates of mortality and severe morbidity in adults, previously healthy children can usually…
CDC says there have been 158 confirmed cases of acute flaccid myelitis in 36 states
Policies optimizing competing goals and defining training competency needed
More female, black, and Hispanic matriculants seen after diversity accreditation standards implemented